Navigation Links
Thomas Jefferson University honoring Axel Ullrich with Lennox K. Black International Prize
Date:11/26/2012

PHILADELPHIAThomas Jefferson University will honor the renowned biotech researcher whose discoveries led to a slew of innovative drugs that revolutionized treatment including Herceptinone of the first gene-based medications for breast cancerwith its prestigious Lennox K. Black International Prize for Excellence in Biomedical Research.

Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, will receive the recognition for his work in individualized medicine during a two-day symposium that will feature speakers from Jefferson, the National Institutes of Health (NIH), Johns Hopkins University, Genentech and former Kimmel Cancer Center at Jefferson Director Carlo Croce, M.D., Director of the Human Cancer Genetics Program at The Ohio State University.

The symposium, "Individualized Medicine," will be held November 29 and 30 on the Jefferson campus at the Dorrance H. Hamilton Building, Connelly Auditorium, 1001 Locust Street. The prize award and keynote speech by Dr. Ullrich will begin at 2:30 p.m. on Nov. 29. Michael J. Vergare, M.D., Senior Vice President of Academic Affairs, and Professor and Chair of the Department of Psychiatry at Jefferson, will present the award to Dr. Ullrich on behalf of the University.

The prize is awarded every two years to recognize the impact of pioneering biomedical research on the alleviation of human disease and suffering. Another goal is to draw the international scientific research community together in recognition of the ability of the spirit of human inquiry to transcend national boundaries and divisions.

For the past 25 plus years, Dr. Ullrich has been a leader in the biotechnology world, translating many of his basic science discoveries into clinical applications. Dr. Ullrich and his team's research led to the development of the drug Humulin (human insulin for diabetes), which is the first therapeutic agent ever to be
'/>"/>

Contact: Steve Graff
stephen.graff@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. ASH awards Timothy J. Ley, M.D., with 2012 E. Donnall Thomas Lecture and Prize
2. HIV drug may slow down metastatic breast cancer, say researchers at Jeffersons Kimmel Cancer Center
3. University of Cincinnati researchers win $3.7M grant from US Department of Defense
4. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
5. Rice University student engineers automate limb lengthening for kids
6. Louisiana Tech University professor earns NSF Early Career Development grant
7. Neuropsychologist receives University of Houstons highest faculty honor
8. University of Houston Graduate College of Social Work announces partnership with MD Anderson
9. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
10. University of Minnesota startup to treat challenging bacterial infection
11. University studies and career expectations of medical students
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Thomas Jefferson University honoring Axel Ullrich with Lennox K. Black International Prize
(Date:6/1/2015)... 2015 "This milestone opens the doors ... previously able to buy and sell shares of our ... and also make recommendations to clients as they so ... to trade shares of our Company,” said Kris Finstad, ... requirements of OTCQB provides our investors greater confidence in ...
(Date:6/1/2015)... Pittsburgh, PA (PRWEB) June 01, 2015 ... this new development in breast cancer prevention. , A ... Health suggests that postmenopausal women with ductal carcinoma in ... cancer treatment and prevention. , The study (NSABP B-35/NRG ... those who completed the standard five-year treatment with tamoxifen ...
(Date:6/1/2015)... For years, facial plastic surgery demands ... like one would request a hairstyle, patients would use ... and more to illustrate their adaptation of choice. However, ... ushering in a new era of aesthetic envy – ... Rizk, MD, FACS notes that since the explosion of ...
(Date:6/1/2015)... There’s never a good time to be sick ... minor illnesses. , As of June 1, OSF HealthCare is ... care via the Internet. Patients throughout Illinois can access care ... “Everyone is busy. We know that getting in to see ... to make it easier,” said Jeffry Tillery, MD, Chief Transformation ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 June 1, ... of clinical journals in the areas of hospital medicine, ... announce that it has expanded upon its partnership with ... Hospital Medicine Practice, in a mobile application format ... tablets. , “We are very excited about the ...
Breaking Medicine News(10 mins):Health News:Content Checked Holdings Inc. Upgrades to the OTCQB Marketplace, now available for trading as CNCK 2Health News:Content Checked Holdings Inc. Upgrades to the OTCQB Marketplace, now available for trading as CNCK 3Health News:Content Checked Holdings Inc. Upgrades to the OTCQB Marketplace, now available for trading as CNCK 4Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:Instagram Filters Launch New Facial Plastic Surgery Trend 2Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 3
... Serena Gordon HealthDay Reporter , WEDNESDAY, May ... the drug lenalidomide can significantly lengthen the time that ... disease, either after having a stem cell transplant or ... studies is whether or not the improved "progression-free" survival ...
... today released a wide-ranging compendium of resources ... and secure sharing of health information. ... Policies in Practice for Health Information Sharingor ... for electronic health information sharing, including informed ...
... Infectious diseasesboth old and newcontinue to exact a devastating ... the world. Vaccines remain the best line of ... Stephen Johnston, researchers at Arizona State University,s Biodesign Institute, ... Texas Southwestern Medical Center are using clever functional screening ...
... -- The rate at which Americans are hospitalized for stroke ... According to the U.S. National Center for Health Statistics (NCHS), ... people during the 1990s but had decreased again to under ... there were still about 800,000 hospitalizations for stroke in 1989 ...
... support and limited pressure to achieve the ,thin and beautiful, ... a new study looking at five factors that may help ... the context of a society where discontent with appearance is ... the University of Arizona in the US, and colleagues is ...
... HealthDay Reporter , TUESDAY, May 8 (HealthDay News) ... atrial fibrillation face a 14 percent greater risk of ... report. The raised risk remained higher even when ... stroke, the study authors noted. "Previously, there was ...
Cached Medicine News:Health News:New Drug Shows Promise for Myeloma Patients 2Health News:New Drug Shows Promise for Myeloma Patients 3Health News:Markle releases new resources for health information sharing implementation 2Health News:Markle releases new resources for health information sharing implementation 3Health News:Advanced genetic screening method may speed vaccine development 2Health News:Advanced genetic screening method may speed vaccine development 3Health News:Advanced genetic screening method may speed vaccine development 4Health News:Rate of Hospitalizations for Stroke Has Declined in U.S. 2Health News:Self-worth needs to go beyond appearance 2Health News:Irregular Heartbeat Poses Greater Stroke Risk for Women Than Men 2
(Date:6/1/2015)... , June 1, 2015   Royal Philips  (NYSE: ... Magnetic Resonance (MR) solutions to be showcased at the ... 23 rd Annual Meeting & Exhibition in ... Philips booth #301 will see the latest in ... increase clinical performance, enhance patient experience and provide economic ...
(Date:6/1/2015)... June 1, 2015 Novel t ... drive growth , says   GBI Research ... (NSCLC) treatment market will be driven primarily by the introduction ... treatment settings, which either replace or combine with generic chemotherapies. ... Non-Small Cell Lung Cancer Market to 2020 - ...
(Date:6/1/2015)... CEFALY Technology , the creators of ... authorized for use prior to the onset of migraine ... trial showing that the Cefaly device returns normal metabolic ... patients, namely the orbitofrontal cortex and rostral cingulate. ... an imaging test of the brain, used a radioactive substance called a ...
Breaking Medicine Technology:Philips showcases MR research solutions designed to enable collaboration with partners at the ISMRM Annual Meeting 2Philips showcases MR research solutions designed to enable collaboration with partners at the ISMRM Annual Meeting 3New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 3New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2
... TAINAN, Taiwan, Aug. 31 /PRNewswire-Asia/ -- ... ... var shortURL = ""; ... we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; ...
... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ... for (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) { ...
Cached Medicine Technology:ScinoPharm to Invest in Tanvex Biologics 2ScinoPharm to Invest in Tanvex Biologics 3ScinoPharm to Invest in Tanvex Biologics 4ScinoPharm to Invest in Tanvex Biologics 5ScinoPharm to Invest in Tanvex Biologics 6PharmaVentures Appoints Paul Phull as Senior Director 2PharmaVentures Appoints Paul Phull as Senior Director 3PharmaVentures Appoints Paul Phull as Senior Director 4PharmaVentures Appoints Paul Phull as Senior Director 5PharmaVentures Appoints Paul Phull as Senior Director 6
... and VersaStep™ PLUS Reposable system components for creating each ... radial expandable sleeve is packaged sterile together with either ... Insufflation and access needle is packaged non-sterile; 5 ... are packaged non-sterile; 5 mm, 7/8 mm, 10 ...
SURGISPIKE™ Single Use 5 mm Trocar. , ,Bladed Trocars are devices that contain a metal blade to gain access to the abdominal cavity....
... The complete line of Surgical Access ... ,The OnePort™ trocar system is actually ... be versatile, operationally flexible and clinically adaptive ... offering options in disposability and bladed or ...
... line of Surgical Access ...unlike any trocar ... trocar system is actually four systems in ... flexible and clinically adaptive to all of ... disposability and bladed or dilating tip styles, ...
Medicine Products: